ALKL1196M –ABT199 interactions. حسب Richard Junior Zapata Dongo (17912565)

الموضوعات:

Identification of DEGs and DESRGs of AD in the GSE52093 dataset. حسب Wei He (131453)

الموضوعات:

ALK^wt–ABT199 interactions. حسب Richard Junior Zapata Dongo (17912565)

الموضوعات:

ALK inhibitors (Positive control) and ABT199 (Proposed binding) in complex with the ALK active side. حسب Richard Junior Zapata Dongo (17912565)

الموضوعات:

Comparative Analysis of Hela Cells Cultured under Static Conditions and Exposed to Fluid Shear Stress. حسب Xinyao Zhao (5824427)

الموضوعات:

Visualization of immune cell infiltration between AD and control group. حسب Wei He (131453)

الموضوعات:

BCL2 protein keeps their expression in different conditions treatment nevertheless each EML4-ALK cell modells exhibit variable expression. حسب Richard Junior Zapata Dongo (17912565)

الموضوعات:

Combination therapy exhibited apoptosis in Ba/F3 EML4-ALKmutant cell models. حسب Richard Junior Zapata Dongo (17912565)

الموضوعات:

miR-1247-3p was downregulated in CRC resistant cells. حسب Dequan Wang (6007007)

الموضوعات:

The binding energy values of ATP, ALK inhibitors and ABT-199 to ALK were obtained from AlphaFold and modeled protein structures. حسب Richard Junior Zapata Dongo (17912565)

الموضوعات:

Downregulation of miR-1247-3p inhibited apoptosis and reduced chemosensitivity in cells. حسب Dequan Wang (6007007)

الموضوعات:

Loewe synergy-antagonism score analysis shows additive and synergistic effects after ALKi and ABT-199 combination treatment. حسب Richard Junior Zapata Dongo (17912565)

الموضوعات:

miR-1247-3p was downregulated in tissues of patients with CRC and was associated with prognosis and drug resistance. حسب Dequan Wang (6007007)

الموضوعات:

Overexpression of miR-1247-3p promoted apoptosis and inhibited resistance in drug-resistant cells. حسب Dequan Wang (6007007)

الموضوعات:

Amino acids interactions and binding energy describe that ABT-199 binds to ALK^Mutant. حسب Richard Junior Zapata Dongo (17912565)

الموضوعات:

BCL2 antiapoptotic protein exhibits heterogeneous expression in Ba/F3 EML4-ALK^mutants. حسب Richard Junior Zapata Dongo (17912565)

الموضوعات:

Ba/F3 EML4-ALK^mutants exhibit variable dose-response to ABT-199 treatment. حسب Richard Junior Zapata Dongo (17912565)

الموضوعات:

Molecular docking showed that ABT-199 can fit into active site of ALK^Mutant. حسب Richard Junior Zapata Dongo (17912565)

الموضوعات:

PBM significantly reduces hyperphosphorylation of tau with no effect on total tau expression. حسب Kevin J. Johnson (2647639)

Reinforcement of calcareous sand columns. حسب Jin Zhu (164147)

الموضوعات: